Neuropace, Inc. · NASDAQ:NPCE

Morrell Martha had 358 Neuropace, Inc. shares withheld for tax (Form 4)

Traded May 27, 2026 · Filed May 28, 2026

On May 27, 2026, Morrell Martha (CHIEF MEDICAL OFFICER) had 358 Neuropace, Inc. shares withheld for tax at US$17.06 for US$6,107, leaving 52,385 shares. Filed May 28, 2026 (Form 4).

Withheld for tax
358 shares
Price
US$17.06
Value
US$6,107
Holding after
52,385 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockShares withheld for tax358US$17.0652,385Direct

Source

View original at SEC

Related